ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 106 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,592,000 | +847.1% | 1,093,199 | +465.3% | 0.00% | – |
| Q3 2019 | $696,000 | +21.3% | 193,400 | -9.7% | 0.00% | – |
| Q2 2019 | $574,000 | -1.5% | 214,100 | +8.7% | 0.00% | – |
| Q1 2019 | $583,000 | +85.1% | 196,900 | -0.7% | 0.00% | – |
| Q4 2018 | $315,000 | -53.7% | 198,300 | +7.1% | 0.00% | – |
| Q3 2018 | $681,000 | +30.0% | 185,100 | 0.0% | 0.00% | – |
| Q2 2018 | $524,000 | -11.2% | 185,100 | +16.3% | 0.00% | – |
| Q1 2018 | $590,000 | +45.0% | 159,100 | +12.5% | 0.00% | – |
| Q4 2017 | $407,000 | -47.1% | 141,400 | -17.4% | 0.00% | -100.0% |
| Q3 2017 | $769,000 | -2.2% | 171,200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $786,000 | +1.8% | 171,200 | -6.7% | 0.00% | 0.0% |
| Q1 2017 | $772,000 | -6.7% | 183,400 | -8.5% | 0.00% | 0.0% |
| Q4 2016 | $827,000 | -49.0% | 200,363 | +0.1% | 0.00% | 0.0% |
| Q3 2016 | $1,622,000 | +3.8% | 200,200 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,562,000 | +1.0% | 200,200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,546,000 | -27.8% | 200,200 | +0.9% | 0.00% | -50.0% |
| Q4 2015 | $2,140,000 | +53.5% | 198,340 | -1.7% | 0.00% | +100.0% |
| Q3 2015 | $1,394,000 | -95.7% | 201,700 | -94.5% | 0.00% | -96.3% |
| Q2 2015 | $32,446,000 | -9.2% | 3,662,082 | +1.0% | 0.03% | -6.9% |
| Q1 2015 | $35,736,000 | +1655.2% | 3,624,331 | +2080.7% | 0.03% | +1350.0% |
| Q4 2014 | $2,036,000 | +6.7% | 166,200 | -13.1% | 0.00% | 0.0% |
| Q3 2014 | $1,908,000 | +31.9% | 191,200 | 0.0% | 0.00% | +100.0% |
| Q2 2014 | $1,447,000 | +199.0% | 191,200 | +29.9% | 0.00% | – |
| Q1 2014 | $484,000 | +0.8% | 147,200 | +1.8% | 0.00% | – |
| Q4 2013 | $480,000 | -14.3% | 144,600 | -22.0% | 0.00% | -100.0% |
| Q3 2013 | $560,000 | -61.5% | 185,500 | +4.3% | 0.00% | -50.0% |
| Q2 2013 | $1,454,000 | – | 177,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |